20-hydroxy-5,8,11,14-eicosatetraenoic acid and Kidney Failure, Chronic

20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Kidney Failure, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Afshinnia, F; Byun, J; Chen, J; Deo, R; Feldman, HI; Fischer, MJ; Hamm, L; Michailidis, G; Miller, ER; Pennathur, S; Rhee, EP; Sharma, K; Wernisch, S; Zeng, L	1

Other Studies

1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Kidney Failure, Chronic

Article	Year
Elevated lipoxygenase and cytochrome P450 products predict progression of chronic kidney disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2020, 02-01, Volume: 35, Issue:2 Topics: Case-Control Studies; Cohort Studies; Cytochrome P-450 Enzyme System; Disease Progression; Female; Humans; Hydroxyeicosatetraenoic Acids; Kidney Failure, Chronic; Lipoxygenase; Male; Middle Aged; Renal Insufficiency, Chronic	2020

Article

Year

Elevated lipoxygenase and cytochrome P450 products predict progression of chronic kidney disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2020, 02-01, Volume: 35, Issue:2

Topics: Case-Control Studies; Cohort Studies; Cytochrome P-450 Enzyme System; Disease Progression; Female; Humans; Hydroxyeicosatetraenoic Acids; Kidney Failure, Chronic; Lipoxygenase; Male; Middle Aged; Renal Insufficiency, Chronic

2020